MKI67 and breast cancer: Only recently have radiomics and AI techniques been applied to simultaneous 18F-FDG PET/MRI for a comprehensive analysis of molecular subtype, Ki67 expression, nodal status, and presence of distant metastasis in a population of 124 BC patients [20].